Active Pharmaceutical Ingredients
Aceclofenac is a widely used non-steroidal anti-inflammatory drug (NSAID) with analgesic and anti-inflammatory properties. The sustained-release (SR) granule formulation is designed to provide extended therapeutic action, reduce dosing frequency, and improve patient compliance while minimizing gastrointestinal side effects.
| Component | Function |
|---|---|
| Aceclofenac | Active Pharmaceutical Ingredient (API) |
| Hydroxypropyl Methylcellulose (HPMC) | Binder / Film former during layering |
| Talc / Colloidal Silicon Dioxide | Anti-adherent / Glidant |
| Ethylcellulose (EC) / HPMC-based polymers | Sustained-release matrix or coating polymer |
| Triethyl Citrate / PEG 6000 | Plasticizer (for coating flexibility) |
| Purified Water | Solvent (evaporated during processing) |
Outsourcing DC Granules through a trusted partner like Salius Pharma can be a strategic decision to save both time and resources, without compromising on quality or compliance.
Instead, partnering with Salius Pharma—a leading distributor aligned with USFDA-approved and WHO-GMP-certified manufacturers in India—allows you to leverage high-quality products, seamless logistics, and professional support under one roof.
We ensure prompt and reliable shipping worldwide. Delivery times may vary depending on destination, order volume, and regulatory requirements.
Looking to source Aceclofenac SR Granules or other high-quality pharmaceutical pellet formulations?
Whether you need Active Pharmaceutical Ingredients (APIs), excipients, or regulatory support, our team is ready to provide reliable, compliant, and cost-effective solutions tailored to your market needs.
The contents of this page and any attachments are intended solely for the designated recipient(s) and may contain confidential and/or privileged information protected by law.
Any patented products are excluded from our offerings in regions where such patents are currently in force.
They are used in the management of chronic inflammatory conditions like osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis.
Aceclofenac SR Granules are supplied with complete regulatory documentation including Certificate of Analysis (CoA), Manufacturing License, GMP Certificate, MSDS, Stability Data, and Product Specifications. Drug Master File (DMF) and CTD sections can be provided on request, subject to market and regulatory requirements.
The sustained-release granules can be customized for dissolution and release kinetics to meet country-specific regulatory or customer requirements, subject to feasibility and validation.